Browse

sophiris

Popular Today
Popular Today
Popular All Time
Newest
Kantardziski Kantardziski PRO SPHS, M, Long
SPHS: Sophiris (SPHS) Multi-month Ascending Broadening Wedge - Bullish
98 0 1
SPHS, M Long
Sophiris (SPHS) Multi-month Ascending Broadening Wedge - Bullish

SPHS is in a multi-year ABW and with the latest partial decline, in addition to other important fundamental and technical factors, it will likely breakout upwards - To infinity and beyond!!

trademan1 trademan1 SPHS, D, Long
SPHS: SPHS Oversold, Filling the Gap, cash/share > share price
156 2 0
SPHS, D Long
SPHS Oversold, Filling the Gap, cash/share > share price

Sophiris Bio had a Phase III drug trial test showing the drug was not effective and the market overreacted. The chart has a cash/share value (mrq) of $1.74, the float is 16.78 Million Shares (note today's volume alone is a large part of that), so with a tiny float, more cash per share on hand than the market price, and upcoming results for new Phase III results ...

United States
United Kingdom
India
Deutschland
España
France
Italia
Polska
Brasil
Россия
Türkiye
Indonesia
Malaysia
日本
한국
Home Stock Screener Forex Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing Priority Support Ideas Published Followers Following Private Messages Chat Sign Out